In biotechnology, the rank and file are well-to-do.
Many of the highest-paying employers in the health-care sector—and the entire S&P 500—were biotech companies, according to an analysis by The Wall Street Journal of annual disclosures for hundreds of big U.S. companies as provided by MyLogIQ.
New Jersey-based Celgene Corp. , which sells a treatment of multiple myeloma, had the highest-paid median employee in the sector and S&P 500 at $263,237. Celgene was followed by Boston-based Vertex Pharmaceuticals Inc., VRTX 1.61% which makes treatments for cystic fibrosis and infectious diseases, paying its typical worker $232,178.
Compensation committees at S&P 500 companies are increasingly tying annual bonuses to measures beyond financial…
The pay gap between CEOs and their employees has widened over the past half decade,…
Chip maker Broadcom gave Hock Tan, its chief executive, a $161 million stock award, instantly…
Elon's Musk's $56 billion pay package's upheaval, a hedge fund sanctioned for failing to preserve…
Disclosures about directors' skills and expertise are increasingly coming under the microscope as investors ramp…
On Jan. 1, several of the nation's biggest companies — including Morgan Stanley, Kraft Heinz,…